CVE:MNX

Manitex Capital Stock Forecast, Price & News

C$0.80

-0.01 (-1.23 %)

(As of 08/12/2021)

Add

Compare

Today's Range

C$0.80

▼

C$0.80

50-Day Range

C$0.80

▼

C$0.99

52-Week Range

C$0.67

▼

C$1.30

Volume20,000 shs

Average Volume4,873 shs

Market CapitalizationC$10.05 million

P/E Ratio11.43

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive MNX News and Ratings via Email

Sign-up to receive the latest news and ratings for Manitex Capital and its competitors with MarketBeat's FREE daily newsletter.

About Manitex Capital

Manitex Capital Inc. focuses on acquiring interests in life sciences, cleantech, and sustainable products/technologies companies. The company also holds a portfolio of marketable securities. The company is headquartered in Kirkland, Canada.

Headlines

No headlines for this company have been tracked by MarketBeat.com

Industry, Sector and Symbol

Stock Exchange CVE
Industry Medical Distribution
Sub-IndustryN/A
SectorMedical
Current SymbolCVE:MNX
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.manitexcapital.com
Phone514-693-8844
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesC$-1,043,068.00
Price / Sales-9.63
Cash FlowC$0.45 per share
Price / Cash Flow1.78
Book ValueC$1.34 per share
Price / Book0.60

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares12,561,000
Market CapC$10.05 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.31 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Manitex Capital.

4.7 Community Rank

Outperform Votes
Manitex Capital has received 12 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Manitex Capital has received 5 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Manitex Capital has received 70.59% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Manitex Capital and other stocks. Vote “Outperform” if you believe MNX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MNX will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Manitex Capital does not currently pay a dividend.
Dividend Growth
Manitex Capital does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Manitex Capital insiders have not sold or bought any company stock.

1.9 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of Manitex Capital is 11.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 14.39.
Price to Earnings Ratio vs. Sector
The P/E ratio of Manitex Capital is 11.43, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.41.
Price to Book Value per Share Ratio
Manitex Capital has a P/B Ratio of 0.60. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Manitex Capital (CVE:MNX) Frequently Asked Questions

What stocks does MarketBeat like better than Manitex Capital?

Wall Street analysts have given Manitex Capital a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Manitex Capital wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Manitex Capital's key executives?

Manitex Capital's management team includes the following people:

Mr. Steven Saviuk, Chairman, Pres & CEO (Age 62, Pay $250k)
Ms. Helen Saviuk, CFO & Director
Mr. Ronald S. Perry CA, CPA, Sec. (Age 65)
Mr. Kristof Biniecki, VP of Scientific Affairs - Valeo Pharma Inc
Nathalie Therrien, Vice-Pres of QA & Regulatory Affairs - Valeo Pharma Inc.
Mr. Luc Mainville M.B.A., M.B.A, Sr. VP & CFO of Valeo Pharma Inc (Age 57)

Who are some of Manitex Capital's key competitors?

Some companies that are related to Manitex Capital include KDA Group (KDA), Arjo AB (publ) (ARRJF), EBOS Group (EBO), Health House International (HHI), McKesson Europe (CAKFY), Paragon Care (PGC), Shanghai Pharmaceuticals (SHPMF), Sinopharm Group (SHTDY) and Synergy CHC (SNYR).
View all of MNX's competitors.

What is Manitex Capital's stock symbol?

Manitex Capital trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MNX."

How do I buy shares of Manitex Capital?

Shares of MNX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Manitex Capital's stock price today?

One share of MNX stock can currently be purchased for approximately C$0.80.

How much money does Manitex Capital make?

Manitex Capital has a market capitalization of C$10.05 million and generates C$-1,043,068.00 in revenue each year.

What is Manitex Capital's official website?

The official website for Manitex Capital is www.manitexcapital.com.

How can I contact Manitex Capital?

The company can be reached via phone at 514-693-8844.

This page was last updated on 9/20/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Manitex Capital Stock Forecast, Price & News

About Manitex Capital

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

4.7 Community Rank

Outperform Votes

Underperform Votes

Community Sentiment

0.0 Dividend Strength

Dividend Yield

Dividend Growth

0.0 Company Ownership

Insider Buying vs. Insider Selling

1.9 Earnings and Valuation

Price to Earnings Ratio vs. the Market

Price to Earnings Ratio vs. Sector

Price to Book Value per Share Ratio

Manitex Capital (CVE:MNX) Frequently Asked Questions

What stocks does MarketBeat like better than Manitex Capital?

Who are Manitex Capital's key executives?

Who are some of Manitex Capital's key competitors?

What is Manitex Capital's stock symbol?

How do I buy shares of Manitex Capital?

What is Manitex Capital's stock price today?

How much money does Manitex Capital make?

What is Manitex Capital's official website?

How can I contact Manitex Capital?

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources

MarketRank^™

Overall MarketRank^™